News
New research from Lancaster University reveals the imapct of the pandemic on people with Parkinson's, carers and their families
Treatments targeting a protein called LRRK2 are currently being tested in clinical trials for Parkinson's. Researchers hope they may have the ability to slow the progression of the condition which is something no current treatment can do.
Researchers at Queen Mary University of London have reported results from the first UK study of the early signs of Parkinson's in a highly diverse population.
Researchers in Norway have published results from an early stage clinical study looking at the potential of a dietary supplement for people with Parkinson's.
An update on the work we're doing to try and influence better workforce planning in the Health and Care Bill.
We have been coordinating activity on behalf of the Continuing Healthcare Alliance to try and influence the Health and Care Bill. This activity aims to improve the quality of continuing healthcare from assessment to delivery across England.
Angela Boag from Glasgow has raised over £2000 so far through donations on her JustGiving page
Researchers, including scientists from Queen's University Belfast, have discovered that people with Parkinson's who eat more flavonoids may have a longer life expectancy.
The broadcasting legend is returning for a second 6-part series.
Thanks to our amazing supporters we’ve raised over £1.2m for Parkinson’s Connect. We couldn’t have done this without the incredibly generous support of the Frank Brake Charitable Trust. Together, we’re transforming Parkinson’s.